Staff Reporters
Jun 18, 2019

McCann Health Shanghai wins Pharma Grand Prix

2019 Cannes Lions winners for Pharma: McCann Health Shanghai's Grand Prix and gold are the only APAC awards in the category.

McCann Health Shanghai wins Pharma Grand Prix

McCann Shanghai won the Grand Prix as well as a Gold Lion in this category, awarded Monday night at Cannes Lions 2019.

The wins came for 'Breath of life', an awareness campaign for GSK about chronic obstructive pulmonary disease (COPD). The Grand Prix came under 'Creative Data: Data Visualisation' and the gold came under 'Use of Technology'.

The work used the Chinese art form of blow painting as a mechanism to encourage people to test their breath volume, which can indicate the presence COPD.

There were no other awards to APAC agencies in this category, which had only 11 total awards (one Grand Prix, two gold, three silver and five bronze).

See all our Cannes Lions 2019 award coverage.

McCann Health Shanghai also picked up Agency of the Year honours, and McCann Health was named Health Network of the Year.

Source:
Campaign Asia

Related Articles

Just Published

2 hours ago

StackAdapt launches integrated platform to connect ...

Marketers can now use one workflow to trigger emails from ad views and personalise campaigns using real-time purchase signals.

3 hours ago

Heineken trusts Korean football fans with keys to ...

An activation in Seoul sees Korean fans ordering, paying for, and pulling their own pints without bar owners or security present. Just to be able to watch live football.

3 hours ago

Why sports marketing should lean into intimate, ...

In a world shaped by Gen Z and hyper-local engagement, the winning brands aren’t the loudest—they’re the ones that create authentic experiences that foster belonging and build trust.

4 hours ago

Woolley Marketing: How much transparency is too ...

Trust in advertiser-agency relationships hinges not on absolute transparency, but on reasonable openness that empowers both sides without drowning them in irrelevant details, says Darren Woolley.